摘要
目的综述了微乳载体对药物在体内的吸收、分布及药动学等方面的影响,为制剂研究者在选用微乳这一越来越重要的载药体系提供理论依据和实例参考。方法查阅大量国内外相关文献。结果与结论微乳作为一种新型药物载体具有分散性高、增溶效果好和生物黏附性强等优点,并能提高药物的生物利用度、影响药物的代谢和分布、延长药物在机体内的滞留时间及提高组织靶向性。
关键词
微乳 /
增溶 /
靶向 /
药动学
{{custom_keyword}} /
王春龙;江荣高;刘健华.
微乳体系对药物吸收、分布和药动学的影响[J]. 中国药学杂志, 2008, 43(10): 723-726
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] KIM C K,CHO Y J,GAO Z G. Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery[J] . J Controlled Release,2001,70 (1-2):149-155.
[2] SUBRAMANIAN N,RAY S,GHOSAL S K,et al. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib[J] . Biol Pharm Bull,2004 ,27 (12):1993-1999.
[3] ARAYA H,TOMITA M,HAYASHI M,et al. The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds[J] . Int J Pharm,2005 ,305(1-2):61-74.
[4] LU Y,JIANG X S,ZENG R J. Pharmacokinetics of diclofenac sodium microemulsions in rabbits[J] . Acad J Sec Mil Med Univ (第二军医大学学报),2000,21 (10): 980-982.
[5] LU Y,JIANG X S,ZENG R J,et al. Pharmacokinetics of diclofenac sodium microemulsion in human[J] . Acad J Sec Mil Med Univ (第二军医大学学报),2001,22 (4):364-366.
[6] WANG L,DENG J,JIN Y Y,et al. Comparation of anticoagulation effects of low molecular weight heparin(LMWH) nano-liposomes and microemulsions in rat by oral administration[J] . Jiangsu Pharm Clin Res(江苏药学与临床研究),2005,13 (2):4-6.
[7] LYONS K C,CHARMAN W N,MILLER R,et al. Factors limiting the oral bioavailability of N-acetylglucosaminyl-N- acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion[J] .Int J Pharm,2000,199 (1):17-28.
[8] MENG B Y,PING Q N,XIONG J,et al. Hypoglycemic effect of insulin W/O microemulsions following intestinal administration to rats[J] . J China Pharm Univ(中国药科大学学报),2006,37 (4):304-330.
[9] DUNN C J,WAGSTAFF A J,PERRY C M,et al. Cyclosporin:an updated review of the pharmacokinetic properties,clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation[J] . Drugs,2001,61(13):1957-2016.
[10] BARALDO M,PEA F,POZ D,et al. Pharmacokinetics of two oral cyclosporine A formulations in clinically stable heart-transplant patients[J] .Pharmacol Res,2001 ,43 (6):547-551 .
[11] GHORAB M M. Accelerated oral absorption of ibuprofen in human subjects from soft gelatin capsules containing microemulsion pre-concentrate [J] . Bull Faculty Pharm,2002,40 (1):193-200.
[12] KAWAKAMI K,YOSHIKAWA T,HAYASHI T,et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs Ⅱ in vivo study[J] .J Controlled Release,2002 ,81(1-2):75-82.
[13] CHEN H B,WENG T,CHANG X L,et al. Preparation of ibuprofen microemulsion and its transdermal absorption[J] .Chin Pharm J(中国药学杂志),2004,39 (1):43-45.
[14] KREILGAARD M. Influence of microemulsions on cutaneous drug delivery[J] . Adv Drug Deliv Rev,2002,54 (1):77-98.
[15] PELTOLA S,SAARINEN-SAVOLAINEN P,KIESVAARA J,et al. Microemulsions for topical delivery of estradiol[J] .Int J Pharm,2003 ,254 (2):99-107.
[16] WU H,RAMACHANDRAN C,WEINER N D,et al. Topical transport of hydrophilic compounds using water-in oil nanoemulsiond[J] .Int J Pharm,2001,220 (1-2):63-75.
[17] PAOLINO D,VENTURA C A,NISTICO S,et al. Lecithin microemulsions for the topical administration of ketoprofen:percutaneous adsorption through human skin and in vivo human skin tolerability[J] .Int J Pharm,2002,244 (1-2):21-31.
[18] GETIE M,WOHLRAB J,NEUBERT R H. Dermal delivery of desmopressin acetate using colloidal carrier systems [J] .J Pharm Pharmacol,2005 ,57(4):423-427.
[19] LEE P J,LANGER R,SHASTRI V P. Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs[J] .Pharm Res,2003,20 (2):264-269.
[20] NASSERI A A,ABOOFAZELI R,ZIA H,et al. Lecithin-stabilized microemulsion-based organogels for topical application of ketorolac tromethamine Ⅱ. In vitro release study [J] . Iran J Pharm Res,2003,2 (2):117-124.
[21] SINTOV A C,SHAPIRO L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo[J] .J Controlled Release,2004,95 (2):173-183.
[22] HASS A,KOIPERT S. Development and characterization of microemulsions for ocular application[J] . Eur J Pharm Biopharm,1997,439 (2):179-183.
[23] ALANY R G,RADES T,NICOLL J,et al. W/O Microemulsions for ocular delivery:evaluation of ocular irritation and precorneal retention[J] .J Controlled Release,2006 ,111 (1-2):145-152.
[24] JUNPING W,TAKAYAMA K,NAGAI T,et al. Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid,oleic acid,vitamin E and cholesterol[J] . Int J Pharm,2003,251 (1-2):13-21.
[25] AZEVEDO C H,CARVALHO J P,VALDUGA C J,et al. Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma[J] .Gynecol Oncol,2005,97(1):178-182.
[26] TONG X Y,HUANG C Y,YAO J,et al. Distribution of nimodipine microemulsion in mice in vivo and evaluation on its targeting performance[J] . J China Pharm Univ(中国药科大学学报),2002,33 (4):293-296.
[27] HE L,WANG G L,ZHANG Q. Studies on hypersensitivity and pharmacokinetics of paclitaxel microemulsion[J] .Acta Pharm Sin (药学学报),2003,38 (3):227-230.
[28] LOCKMAN P R,KOZIARA J M,MUMPER R J. et al. Nanoparticle surface charges alter blood-brain barrier integrity and permeability[J] .J Drug Target,2004,12 (9-10):635-641.
[29] ZHAO W,ZHANG X N. Application and investigation of drug nanoparticle-delivery-system in ophthalmology[J] .Chin Ophthalmic Res(眼科研究),2002,20 (2):186-189.
[30] HWANG S R,LIM S J,PARK J S,et al. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration[J] .Int J Pharm,2004 ,276 (1-2):175-183.
[31] LAWRENCE M J,REES G D. Microemulsion-based media as novel drug delivery systems[J] .Adv Drug Deliv Rev,2000 ,45 (1):89-121.
[32] POLLARD S,NASHAN B,JOHNSTON A,et al. Pharmacokinetic and clinical review of the potential clinical impact of using different for mulation of cydosporin A[J] .Clin Ther,2003 ,25 (6):1654-1669.
[33] ZHANG L,XIANG D,HONG Z,et al. Studies on the liver targeting of norcantharindin microemulsion[J] .Acta Pharm Sin(药学学报),2004,39 (8):650-655.
[34] FAWAZ F,BONINI F,MAUGEIN J,et al. Pharmacokinetics and in vitro antimicrobial ctivity ciprofloxacin-loaded polyisobutylcyanoacrylate nanoparticles[J] .Int J Pharm,1998,168 (2):255-259.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}